Researchers at Oregon State University have found that chia seeds hold compounds that could play a role in creating medicines aimed at cancer treatment and lowering high blood pressure. The findings were shared in a reputable scientific publication.
Chia seeds come from Salvia hispanica, a flowering plant in the mint family native to regions of Mexico and Guatemala. They are celebrated for their nutritious profile, delivering ample omega-3 fatty acids, plant-based protein, dietary fiber, and a spectrum of micronutrients that can support overall health.
In examining chia seeds at the molecular level, scientists identified a large set of genes involved in the production of small bioactive peptides. These peptides appear to interact with the digestive, endocrine, cardiovascular, immune, and nervous systems in ways that could support human health as they pass through the digestive tract. The research points to a potential reservoir of bioactive molecules within chia that may influence multiple bodily systems.
Among the most exciting properties highlighted are potential anticancer and antihypertensive effects. Researchers suggest these bioactive components could be enhanced through plant breeding and eventually leveraged in the development of therapies targeting cancer and high blood pressure.
Historical medical guidance has cautioned that licorice should be used carefully by people with hypertension, underscoring the importance of understanding how various natural substances interact with cardiovascular regulation.